PTPI

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PTPI

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	06:07	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2024/05/21	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2024/05/14	20:00	GlobeNewswire Inc.	Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2024/01/13	06:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/30	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/29	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/27	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/27	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/27	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/01	06:07	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/12/01	06:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/11/16	07:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/11/16	07:00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/10/02	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/09/20	05:36	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/09/19	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/09/16	06:16	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/09/16	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/08/26	06:08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/08/16	06:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/08/16	06:01	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/08/15	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/08/12	05:31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/07/22	05:30	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/07/14	05:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/04/29	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/04/29	07:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/04/13	07:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/04/13	07:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTPI	Petros Pharmaceuticals Inc
2023/04/13	07:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTPI	Petros Pharmaceuticals Inc